Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine

Author： Jackman W.T. Mann K.A. Hoffmann H.J. Spaete R.R.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.7, 1999-02, pp. : 660-668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines

By Wilson A.D. Lovgren-Bengtsson K. Villacres-Ericsson M. Morein B. Morgan A.J.

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1282-1290

Elsevier

Access to resources Recommend Favorite

Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine

By Vafai A.

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1336-1338

Elsevier

Access to resources Recommend Favorite

Vaccine against human tumor; comprises a B-lymphocyte immortalized using Epstein-Barr virus and expressing the human mucin gene after plasmid pRep4MUC1 transfection

By Pecher G.

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 461-461

Elsevier

Access to resources Recommend Favorite

A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge

By Bruschke C.J.M. Moormann R.J.M. van Oirschot J.T. van Rijn P.A.

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1940-1945

Elsevier

Access to resources Recommend Favorite

Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?

By Drings A. Jallet C. Chambert B. Tordo N. Perrin P.

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1549-1557

Elsevier

Access to resources Recommend Favorite